Abstract
Bronchial asthma affects pregnant women worldwide. During pregnancy asthma should be adequately treated for the benefit of the mother and the fetus, as severe, poorly treated asthma is associated with adverse perinatal outcomes. This chapter addresses the various medications used for asthma such as short- and long-acting beta agonists, inhaled and systemic corticosteroids, leukotriene modifiers, theophylline, mast cell stabilizers, anticholinergics and anti-IgE treatment. This chapter also addresses the use of mucolytics, expectorants and antitussive pharmacotherapy during pregnancy.
Original language | English |
---|---|
Title of host publication | Drugs During Pregnancy and Lactation |
Subtitle of host publication | Treatment Options and Risk Assessment: Third Edition |
Publisher | Elsevier Inc. |
Pages | 65-74 |
Number of pages | 10 |
ISBN (Electronic) | 9780124079014 |
ISBN (Print) | 9780124080782 |
DOIs | |
State | Published - 2015 |
Keywords
- Anticholinergic
- Antitussive
- Asthma
- Beta agonist
- Corticosteroids
- Cough
- Expectorants
- IgE
- Leukotriene
- Mast cell
- Mucolytics